Secondary prevention of coronary heart disease in the elderly.
Bulpitt
Christopher J
CJ
Care of the Elderly, Division of Medicine, Imperial College School of Medicine, Du Cane Road, London W12 0HS, UK. c.bulpitt@imperial.ac.uk
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001786:Blood Glucose / Q000032:analysis; D003327:Coronary Disease / Q000517:prevention & control*; D006801:Humans; D008019:Life Style; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D001786:Blood Glucose; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin